210 related articles for article (PubMed ID: 26898493)
1. An Experimental Study of Histopathologic Effects of Hemostatic Agents Used in Spinal Surgery.
Altun I
World Neurosurg; 2016 Jun; 90():147-153. PubMed ID: 26898493
[TBL] [Abstract][Full Text] [Related]
2. Effects of hemostatic polysaccharide agent on epidural fibrosis formation after lumbar laminectomy in rats.
Tural Emon S; Somay H; Orakdogen M; Uslu S; Somay A
Spine J; 2016 Mar; 16(3):414-9. PubMed ID: 26582488
[TBL] [Abstract][Full Text] [Related]
3. What happens to hemostatic agents in contact with urine? An in vitro study.
Uribe CA; Eichel L; Khonsari S; Finley DS; Basillote J; Park HK; Li CC; Abdelshehid C; Lee DI; McDougall EM; Clayman RV
J Endourol; 2005 Apr; 19(3):312-7. PubMed ID: 15865520
[TBL] [Abstract][Full Text] [Related]
4. Is the use of hemostatic matrix (Floseal) and alkylene oxide copolymer (Ostene) safe in spinal laminectomies? Peridural fibrosis assessment.
Gurcan O; Gurcay AG; Kazanci A; Onder E; Senturk S; Bavbek M
Acta Orthop Traumatol Turc; 2017 Mar; 51(2):165-168. PubMed ID: 28246047
[TBL] [Abstract][Full Text] [Related]
5. Spinal epidural fibrosis following hemostatic agent employment.
Bozkurt I; Kazanci A; Gurcan O; Gurcay AG; Arikok AT; Bavbek M
Br J Neurosurg; 2023 Apr; 37(2):137-141. PubMed ID: 36939282
[TBL] [Abstract][Full Text] [Related]
6. Efficacy, Security, and Manageability of Gelified Hemostatic Matrix in Bleeding Control during Thoracic and Lumbar Spine Surgery: FloSeal versus Surgiflo.
Landi A; Gregori F; Marotta N; Delfini R
J Neurol Surg A Cent Eur Neurosurg; 2016 Mar; 77(2):139-43. PubMed ID: 26351870
[TBL] [Abstract][Full Text] [Related]
7. The role of FloSeal in reducing epidural fibrosis in a rat laminectomy model.
Dogulu F; Durdag E; Cemil B; Kurt G; Ozgun G
Neurol Neurochir Pol; 2009; 43(4):346-51. PubMed ID: 19742393
[TBL] [Abstract][Full Text] [Related]
8. Combination of a liquid fibrin sealant with sheet-type hemostatic agents: experimental evaluation in partial nephrectomy animal model.
Ishii K; Kawashima H; Hayama T; Asai T; Kamikawa S; Sakamoto W; Miyabashira S; Oka S; Sugimoto T
Int J Urol; 2011 Jun; 18(6):478-82. PubMed ID: 21488977
[TBL] [Abstract][Full Text] [Related]
9. Anti-adhesion properties of a thrombin-based hemostatic gelatin in a canine laminectomy model: a biomechanical, biochemical, and histologic study.
Miyamoto K; Masuda K; Inoue N; Okuma M; Muehleman C; An HS
Spine (Phila Pa 1976); 2006 Feb; 31(4):E91-7. PubMed ID: 16481942
[TBL] [Abstract][Full Text] [Related]
10. Cost-consequence analysis of two different active flowable hemostatic matrices in spine surgery patients.
Makhija D; Rock M; Ikeme S; Kuntze E; Epstein JD; Nicholson G; Price JS; Patel V
J Med Econ; 2017 Jun; 20(6):606-613. PubMed ID: 28287015
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and Safety of a Thrombin-Containing Collagen-Based Hemostatic Agent in Spinal Surgery: A Randomized Clinical Trial.
Park SM; Kang DR; Lee JH; Jeong YH; Shin DA; Yi S; Ha Y; Kim KN
World Neurosurg; 2021 Oct; 154():e215-e221. PubMed ID: 34246825
[TBL] [Abstract][Full Text] [Related]
12. Prospective, randomized, controlled clinical trial of a novel matrix hemostatic sealant in children undergoing adenoidectomy.
Mathiasen RA; Cruz RM
Otolaryngol Head Neck Surg; 2004 Nov; 131(5):601-5. PubMed ID: 15523433
[TBL] [Abstract][Full Text] [Related]
13. Observational evaluation of outcomes and resource utilization from hemostatic matrices in spine surgery.
Price JS; Tackett S; Patel V
J Med Econ; 2015; 18(10):777-86. PubMed ID: 25934148
[TBL] [Abstract][Full Text] [Related]
14. Prospective, randomized clinical trial of the FloSeal matrix sealant in cardiac surgery.
Nasso G; Piancone F; Bonifazi R; Romano V; Visicchio G; De Filippo CM; Impiombato B; Fiore F; Bartolomucci F; Alessandrini F; Speziale G
Ann Thorac Surg; 2009 Nov; 88(5):1520-6. PubMed ID: 19853105
[TBL] [Abstract][Full Text] [Related]
15. Effects of Topical Cova™, Tisseel® and Adcon® Gel Application on the Development of Spinal Peridural Fibrosis: An Experimental Study in Rats.
Kazanci A; Gurcan O; Gurcay AG; Onder E; Kazanci B; Yaman ME; Bavbek M
Turk Neurosurg; 2017; 27(6):962-968. PubMed ID: 27593819
[TBL] [Abstract][Full Text] [Related]
16. Comparative safety and efficacy of topical hemostatic agents in a rat neurosurgical model.
Ereth MH; Schaff M; Ericson EF; Wetjen NM; Nuttall GA; Oliver WC
Neurosurgery; 2008 Oct; 63(4 Suppl 2):369-72; discussion 372. PubMed ID: 18981845
[TBL] [Abstract][Full Text] [Related]
17. Use of fibrin-based sealants and gelatin-matrix hemostats in laparoscopic liver surgery.
Saif R; Jacob M; Robinson S; Amer A; Kei-Hui D; Sen G; Manas D; White S
Surg Laparosc Endosc Percutan Tech; 2011 Jun; 21(3):131-41. PubMed ID: 21654294
[TBL] [Abstract][Full Text] [Related]
18. Comparison of a new fibrin sealant with standard topical hemostatic agents.
Schwartz M; Madariaga J; Hirose R; Shaver TR; Sher L; Chari R; Colonna JO; Heaton N; Mirza D; Adams R; Rees M; Lloyd D
Arch Surg; 2004 Nov; 139(11):1148-54. PubMed ID: 15545559
[TBL] [Abstract][Full Text] [Related]
19. Comparison of a gelatin thrombin versus a modified absorbable polymer as a unique treatment for severe hepatic hemorrhage in swine.
Sánchez Del Valle FJ; De Nicolás L; Fernández G; Fernández P; Gómez E; Aranaz Corral I
Sci Rep; 2023 Nov; 13(1):20854. PubMed ID: 38012204
[TBL] [Abstract][Full Text] [Related]
20. Similar patient outcomes yet different hospital costs between flowable hemostatic agents.
David G; Lim S; Gunnarsson C; Kocharian R; Roy S
J Med Econ; 2015; 18(9):735-45. PubMed ID: 25907200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
